NTLA

NTLA Operating Cash Flow (Statement)

-$346.64MTTM · USD

Period ending:

NTLA FY Cash from OperationsUSD
NTLA FY Cash from Operations2014-12-31: -$3.48M2015-12-31: -$1.76M2016-12-31: $36.11M2017-12-31: -$65.28M2018-12-31: -$61.26M2019-12-31: -$103.24M2020-12-31: -$49.91M2021-12-31: -$225.03M2022-12-31: -$333.29M2023-12-31: -$394.09M2024-12-31: -$348.88M2025-12-31: -$348.88M$36.11M-$394.09M
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NTLA operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Intellia Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-348,880,000
-348,880,000
-394,086,000
-333,287,000
-225,030,000
-49,912,000
-103,240,000
-61,257,000
-65,276,000
36,109,000
-1,763,000
-3,483,000

Compare operating cash flow (statement)

All NTLA financial metrics · NTLA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.